Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT Scan

Cirrhosis Clinical Trial

— GSA  

Official title:

Functional-three-dimensional Reconstruction and Functional Evaluation of Liver by 99MTc-GSA-SPECT Scintigraphy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01350726
• Other study ID #: PUMCH-Liver surgery -GSA
• Status: Recruiting
• Phase: N/A
• First received: May 8, 2011
• Last updated: May 9, 2011
• Start date: January 2008
• Est. completion date: July 2011

Study information

• Verified date: May 2011
• Source: Peking Union Medical College Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The aims of this study were divided into three parts:

1. To develop a new software to carry out the functional-three- dimensional-reconstruction of the liver by 99mTc-GSA-SPECT scintigraphy

2. To probe a new dynamic model of the metabolism of the 99mTc-GSA.

3. To evaluate the liver function by 99mTc-GSA-SPECT scintigraphy before surgical treatment.

Study design:

1. Collectivity type: Prospective，randomized, controlled, multi-central clinical study.

2. Patients: The subjects were from different hospitals including: Peking Union Medical College Hospital (PUMCH).

Study arrangement:

This study was consisted of three parts:

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 0
• Est. completion date: July 2011
• Est. primary completion date: May 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Patients that with benign tumor?hepatitis and hepatic carcinoma (with or without cirrhosis)diagnosed by examination of CT, ultrasound-B, and/or pathology.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Carcinoma, Hepatocellular
• Cirrhosis
• Hepatic Carcinoma

Locations

Country	Name	City	State
China	Peking Union Medical College Hospital	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Peking Union Medical College Hospital

Country where clinical trial is conducted

China,